Tackling social ills like climate change and poverty takes more than throwing money at the problem. It takes social entrepreneurs to attack it from the inside, said Sally Osberg, co-author of Getting Beyond Better. 'Social entrepreneurs attack problems where there is a disadvantaged segment of the population that lacks the power of the means to bring about the change that would make their lives better,' said Osberg, who is also CEO of the Skoll Foundation which sponsors social entrepreneurship. Osberg uses the example of Riders for Health to illustrate how social entrepreneurship differs from other methods of aid. Riders for Health was founded by Andrea and Barry Coleman, who drew on their passions for desert motorcycling to start the organization which makes reliable transportation and vehicle maintenance an integral part of Africa’s health systems. 'They knew what it took to equip people with transportation that would be 100% reliable and to deliver health care effectively, you need that reliability,' said Osberg. 'They went to work and they are now partnering with ministries in five sub-Saharan African countries to build their health delivery transportation system.' Riders for Health differs from microfinance because the project is more about a social than a monetary return. Although she said occasionally a social entrepreneur can turn a profit as well. Most importantly, Riders for Health is a solution that can be scaled and transferred to tackle similar problems elsewhere.
More from Video
Amid the Selling, Here's the Big Question Now
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
One Tweet Pulls the Rug Out From Under the Indexes
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
A Technical Look at the New Dow Jones Industrial Average
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.